foxo4 dri senolytic or senomorphic The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Development of a novel senolytic
Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect Targeting Senescence: A Review of Senolytics and Senomorphics in Anti Aging Interventions
Pay in 4 interest-free payments of $5.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



